David J. Hawksworth
21Patents
5h-index
59Co-inventors
72Inventor score
Filing activity: May 29, 1990 → Apr 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8741287B2 | PlGF-1 assay and kits and components thereof | Physics | 14 | Active |
| US5155212A | Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5434087A | Folate immunoassay utilizing folate binding protein in a multiclonal antibody format | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7858752B2 | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same | Chemistry; Metallurgy | 9 | Active |
| US7731965B2 | Human ring specific BNP antibodies | Chemistry; Metallurgy | 6 | Expired |
| US8349325B2 | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making | Chemistry; Metallurgy | 5 | Active |
| US5407834A | Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit | Emerging Cross-Sectional Technologies | 4 | Expired |
| US9371374B2 | HCV core lipid binding domain monoclonal antibodies | Physics | 3 | Active |
| US8846036B2 | Antibodies that bind to mammalian NGAL and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9636398B2 | Composition and method for the diagnosis and treatment of iron-related disorders | Physics | 1 | Active |
| US8734793B2 | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same | Chemistry; Metallurgy | 1 | Active |
| US9482667B2 | Anti-T. cruzi antibodies and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US10444242B2 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | Physics | 0 | Active |
| US11428694B2 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | Physics | 0 | Active |
| US10308709B2 | Anti-GP73 monoclonal antibodies and methods of obtaining the same | Physics | 0 | Active |
| US11421023B2 | Anti-GP73 monoclonal antibodies and methods of obtaining the same | Physics | 0 | Active |
| US10215754B2 | Anti-T. cruzi antibodies and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US9073984B2 | Anti-T. cruzi antibodies and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US10197573B2 | HCV core lipid binding domain monoclonal antibodies | Physics | 0 | Active |
| US10345311B2 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | Physics | 0 | Active |
| US9469686B2 | Anti-GP73 monoclonal antibodies and methods of obtaining the same | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.